ORBIMED ADVISORS LLC - 31 Dec 2025 SCHEDULE 13G Report for Cybin Inc. Common Stock, no par value (CYBN)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED CAPITAL LLC
Security
Cybin Inc. Common Stock, no par value
Symbol
CYBN
Shares outstanding
49,440,816 shares
Disclosed Ownership
2,422,600 shares
Ownership
4.9%
Form type
SCHEDULE 13G
Filing time
17 Feb 2026, 18:20:47 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ORBIMED ADVISORS LLC disclosed 4.9% ownership in Cybin Inc. Common Stock, no par value (CYBN) on 31 Dec 2025."

Quick Takeaways

  • ORBIMED ADVISORS LLC filed SCHEDULE 13G for Cybin Inc. Common Stock, no par value (CYBN).
  • Disclosed ownership: 4.9%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Feb 2026, 18:20.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 2.8% 1,417,900 0 1,417,900 /s/ Carl L. Gordon Carl L. Gordon/Member
ORBIMED CAPITAL LLC 4.9% 2,422,600 2,422,600 0 /s/ Carl L. Gordon Carl L. Gordon/Member

Sponsored